Bio & Science
Semaglutide patents expire in China and India A stream of generic drugs priced at one-eighth of the list price stands ready Broader access to obesity drugs begins in earnest Wegovy/Photo=Novo Nordisk
Read More
Supply chain risk goes far beyond rare earths Hormuz now matters for tech inputs, not just energy Resilience needs diversification and better risk mapping In 2024, the Strait of Hormuz facilitated over one-quarter of global sea
Read More
Japan proves China dependence is hard to replace, even after years of effort The real task is de-risking, not full decoupling That means coordination, processing capacity, and skilled labor Fifteen years after
Read MoreRound Two of the Global Obesity Drug Boom Convenience-Driven Shift Toward Oral Therapies Competition to Capture the $150 Billion Market Intensifies The paradigm of the obesity treatment market
Read More
Cortical Labs to build commercial data centers in Australia and Singapore using ‘CL1’ Bio-computing emerges as an alternative to AI-driven power shortages, demonstrating potential for intelligent information processing Experts caution the technology remains in an early stage despite intensifying development race
Read More
As the patent expiration of semaglutide nears in China, will price competition begin in earnest The biopharmaceutical industry is also accelerating development of new drugs to rival Wegovy Competition is expanding to secure next-generation obesity treatments such as oral drugs
Read More
Solar subsidies helped drive the dramatic fall in solar energy costs But geography determines who benefits most from cheap solar Smart policy must match solar expansion with regional cooperation and grid investment Solar subsidies h
Read More
Sodium-ion batteries promise cheaper, safer energy storage The technology still needs large-scale testing and validation Targeted deployment could reshape clean energy systems The rise of sodium-ion batteries could be a tran
Read More
China’s rare earth dominance comes mainly from processing technology Supply disruptions often trigger innovation elsewhere Critical minerals cooperation is key for resilient supply chains In 2024, data indicate that Ch
Read More
Beijing Steps Up Support for BCI Sector, Driving Surge in Clinical Trials and Investment Industry Frontrunner Neuralink Accelerates Mass Production and Portfolio Expansion FDA Regulatory Overhang Weighs on Neuralink, Raising Commercialization Barriers
Read More
Appetite is not a single switch but a network that can now be powerfully overridden Multi-pathway obesity drugs deliver record weight loss while introducing new biological risks Policy and education must adapt as fast as the science does
Read More
Beliefs shape perception before evidence is even processed Video and data do not correct bias; they often reinforce it Education systems must redesign how evidence is interpreted, not just collected It's not as simple as people s
Read More
China’s power in rare earths comes from refining, not mining African supply backed by Australia and India will not shift leverage without downstream processing and skills Without investment in finishing capacity, diversification will deepen existing dependence
Read More
The Central Asia green transition will follow the fastest, cheapest supply chains The EU can lead on standards, skills, and grid readiness, even if China supplies hardware Central Asia keeps control by demanding open data and local capacity in every deal
Read More
Moderate quakes cause deep, unpriced losses through financing gaps Price mid-risk and pre-fund rapid recovery with layered instruments Trigger cash to schools to cut spreads and speed rebuilding Earthquakes are a relentl
Read More